Adenosine Receptor May Offer Way of Moderating Immune Response in Lupus
Researchers found a specific class of adenosine receptors called A2A that works to counter the immune cell hyperactivation observed in systemic lupus erythematosus (SLE) patients, and may be a new target for disease treatment. The study, “A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus…